Michael Dietrich

Executive Director, Policy

Innovative Medicines Canada

All Sessions by Michael Dietrich

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

3:00 pm

3:00 pm


Critical Elements for a National Strategy and Framework

With Health Canada preparing for the development and implementation of a national strategy for high-cost drugs for rare diseases, what can we learn from the COVID-19 vaccine journey? Leverage the experience of these market leaders to inform your market access strategy. Establish your game plan by:

  • Determining the types of partnerships and funding that will be key to the successful development of drugs for rare diseases
  • Analyzing the impact of recently increased government funding on the overall treatment pipeline
  • Visualizing potential safe and expeditious routes to commercialization for these medicines 

Chart a course to succeed in the new market access model for rare disease therapies

Agenda: Day 2 Oct 6, 2020